Search Results - "Dollinger, Matthias M."

Refine Results
  1. 1
  2. 2
  3. 3

    Human bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury by Stock, Peggy, Brückner, Sandra, Winkler, Sandra, Dollinger, Matthias M, Christ, Bruno

    “…Mesenchymal stem cells from human bone marrow (hMSC) have the potential to differentiate into hepatocyte-like cells in vitro and continue to maintain important…”
    Get full text
    Journal Article
  4. 4

    Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo by Sgodda, Malte, Aurich, Hendryk, Kleist, Sina, Aurich, Ines, König, Sarah, Dollinger, Matthias M., Fleig, Wolfgang E., Christ, Bruno

    Published in Experimental cell research (01-08-2007)
    “…Mesenchymal tissues harbour stromal cells capable of multilineage differentiation. Here, we demonstrate the isolation of mesenchymal stem cells (MSC) from rat…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effect of ET‐A blockade on portal pressure and hepatic arterial perfusion in patients with cirrhosis: A proof of concept study by Zipprich, Alexander, Gittinger, Fleur, Winkler, Matthias, Dollinger, Matthias M., Ripoll, Cristina

    Published in Liver international (01-03-2021)
    “…Background/aim Endothelin causes vasoconstriction via the endothelin‐A receptor (ET‐A) in the intrahepatic circulation in cirrhosis and its increase leads to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Prognostic indicators of survival in patients with compensated and decompensated cirrhosis by Zipprich, Alexander, Garcia-Tsao, Guadalupe, Rogowski, Sebastian, Fleig, Wolfgang E., Seufferlein, Thomas, Dollinger, Matthias M.

    Published in Liver international (01-10-2012)
    “…Background/Aims Patients with cirrhosis are classified in a compensated and a decompensated stage. Portal hypertension is responsible for most of the…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver by Christ, Bruno, Stock, Peggy, Brückner, Sandra, Ebensing, Sabine, Hempel, Madlen, Dollinger, Matthias M

    Published in Nature protocols (01-04-2010)
    “…Donor organ shortage is still the major obstacle for the clinical application of hepatocyte transplantation in the treatment of liver diseases. However,…”
    Get full text
    Journal Article
  12. 12

    Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers by Aurich, Ines, Mueller, Lutz P, Aurich, Hendryk, Luetzkendorf, Jana, Tisljar, Kai, Dollinger, Matthias M, Schormann, Wiebke, Walldorf, Jens, Hengstler, Jan G, Fleig, Wolfgang E, Christ, Bruno

    Published in Gut (01-03-2007)
    “…Aims: At present, clinical success of hepatocyte transplantation as an alternative to whole liver transplantation is hampered by the limited availability of…”
    Get full text
    Journal Article
  13. 13

    CD13: Waving the flag for a novel cancer stem cell target by Christ, Bruno, Stock, Peggy, Dollinger, Matthias M., Kowdley, Kris, McCaughan, Geoffrey, Trautwein, Christian

    Published in Hepatology (Baltimore, Md.) (01-04-2011)
    “…Cancer stem cells (CSCs) are generally dormant or slowly cycling tumor cells that have the ability to reconstitute tumors. They are thought to be involved in…”
    Get full text
    Journal Article
  14. 14

    Thymostimulin in advanced hepatocellular carcinoma: a phase II trial by Dollinger, Matthias M, Behrens, Christa M, Lesske, Joachim, Behl, Susanne, Behrmann, Curd, Fleig, Wolfgang E

    Published in BMC cancer (13-03-2008)
    “…Thymostimulin is a thymic peptide fraction with immune-mediated cytotoxicity against hepatocellular carcinoma in vitro. In a phase II trial, we investigated…”
    Get full text
    Journal Article
  15. 15

    Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis by Zipprich, Alexander, Kuss, Oliver, Rogowski, Sebastian, Kleber, Gerhard, Lotterer, Erich, Seufferlein, Thomas, Fleig, Wolfgang E, Dollinger, Matthias M

    Published in Gut (01-07-2010)
    “…The Model for End Stage Liver Disease (MELD) predicts mortality in end stage liver disease. Incorporation of serum sodium into the MELD may improve diagnostic…”
    Get more information
    Journal Article
  16. 16

    Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients? by Walldorf, Jens, Krummenerl, Annette, Engler, Kristin, Busch, Juliane, Dollinger, Matthias M., Seufferlein, Thomas, Albert, Jörg G.

    Published in Journal of Crohn's and colitis (01-12-2013)
    “…Osteoporosis is a frequent complication of inflammatory bowel disease (IBD). It may be related to IBD itself or to its therapy. In this study, the quality of…”
    Get full text
    Journal Article
  17. 17

    The generation of hepatocytes from mesenchymal stem cells and engraftment into the liver by Christ, Bruno, Dollinger, Matthias M

    Published in Current opinion in organ transplantation (01-02-2011)
    “…Liver transplantation is the ultimate therapeutic option for the treatment of end-stage liver diseases, which, however, is restricted by the shortage of donor…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis by Graham, A M, Dollinger, M M, Howie, S E, Harrison, D J

    “…Primary biliary cirrhosis (PBC) is characterized by progressive, immune-mediated destruction of bile ducts (<75 microm diameter) and secondary changes related…”
    Get more information
    Journal Article